Jack Hirschowitz is a Psychiatry physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 85 publications with 1,951 citations (h-index 25); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
903 Park Ave
Suite 2a
New York, NY 100210338
Telephone
212-410-3376Registry record last updated 15 Jan 2016.
Clinical trials
- Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
Sponsor: Icahn School of Medicine at Mount Sinai
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2005–2007 per NIH RePORTER. The latest:
- SEROQUEL WITH FLUOXETINE FOR IMPROVING RESPONSE TO ANTIDEPRESSANT MEDICATION
Icahn School of Medicine at Mount Sinai
FY2007$11,549M01RR000071 - SEROQUEL (QUETIAPINE) WITH FLUOXETINE FOR IMPROVING ANTIDEPRESSANT RESPONSE
Icahn School of Medicine at Mount Sinai
FY2006$12,333M01RR000071 - SEROQUEL (QUETIAPINE) WITH FLUOXETINE FOR IMPROVING ANTIDEPRESSANT RESPONSE
Mount Sinai School of Medicine of Nyu
FY2005$1,812M01RR000071
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances
Harvard Review of Psychiatry
2010 - A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
International Clinical Psychopharmacology
2008 - Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness
Journal of Clinical Psychopharmacology
2007 - Challenges for Psychiatry in Serving Homeless People With Psychiatric Disorders
Psychiatric Services
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”